The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Shifting IP Constituencies

19 responses to “Shifting IP Constituencies

  1. Pingback: Trends Update — Shifting IP Constituencies: Perkin Elmer and Mylan in India, Branded Generics Everywhere and China’s R&D Budget all Point to Change « The Cross-Border Biotech Blog

  2. Pingback: Trends Update — IP Constituencies: Rotman Article Explores Canadian Biotech Collaborations with Developing Countries « The Cross-Border Biotech Blog

  3. Pingback: Trends Update — IP Constituencies: Amylin Partners with Biocon, PerkinElmer Buys Access and Capacity in India and China « The Cross-Border Biotech Blog

  4. Pingback: Rotman article explores Canadian biotech collaborations with developing countries « The RIC Blog

  5. Pingback: Trends Update — IP Constituencies: India M&A Spurs Pricing Concerns « The Cross-Border Biotech Blog

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Follow

Get every new post delivered to your Inbox.

Join 129 other followers